title: Reproductive Endocrinology in Recurrent Pregnancy Loss.
abstract: Endocrine disruptions may be important in patients experiencing recurrent pregnancy loss (RPL). This review focuses on data available on RPL and the endocrine system to investigate relevant, and perhaps modifiable, endocrine factors of importance for the disorder. Evidence indicates that some hormones may be important as immune modulators and a better understanding of this interplay has potential for improving pregnancy outcome in RPL. To date there is a lack of consensus on the effect of endocrine treatment options in RPL and there is a strong need for large randomized-controlled trials.
authors.affiliation: *The RPL Unit, Fertility Clinic, Copenhagen University Hospital, Copenhagen, Denmark †Department of Obstetrics and Gynaecology, Aalborg University Hospital, Aalborg, Denmark.
authors.forename: Maria C
authors.initials: MC
authors.lastname: Krog
authors.forename: Henriette Svarre
authors.initials: HS
authors.lastname: Nielsen
authors.forename: Ole B
authors.initials: OB
authors.lastname: Christiansen
authors.forename: Astrid M
authors.initials: AM
authors.lastname: Kolte
mesh_terms: D000026:Abortion, Habitual / Q000209:etiology*; D004700:Endocrine System Diseases / Q000150:complications*; D005260:Female; D006801:Humans; D008183:Luteal Phase / Q000378:metabolism*; D011085:Polycystic Ovary Syndrome / Q000150:complications*; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D012307:Risk Factors; D014808:Vitamin D Deficiency / Q000150:complications*